Citations

Showing 10 of 108094 citations.

Echocardiographic parameters and hemodynamic instability at the initiation of continuous kidney replacement therapy
Kompotiatis, Panagiotis , Shawwa, Khaled , Kashani, Kianoush , Kashani, Kianoush B , Jentzer, Jacob C. , Wiley, Brandon M.

Mayo Clinic

Journal of Nephrology | July 18, 2022 | Volume: 36 | Issue: 1 | Pages: 173-181

10.1007/s40620-022-01400-2 | PMID 35849262 Get It

Abstract Objective Investigate the association of echocardiographic parameters with hemodynamic instability after initiating continuous kidney replacement therapy (CKRT) in a cohort of intensive care unit (ICU) patients requiring CKRT. Methods Historical cohort study of consecutive adults admitted to the ICU at a tertiary care hospital from December 2006 through November 2015 who underwent CKRT and had an echocardiogram done within seven days before CKRT initiation. The primary outcome was hypotension within one hour of CKRT initiation. Results We included 980 patients, 804 (82%) with acute kidney injury (AKI) and 176 (18%) with end-stage kidney disease (ESKD). Median patient age was 63 (± 14) years, and median Sequential Organ Failure Assessment (SOFA) score on the day of CKRT initiation was 12 (IQR 10–14). Multivariable analysis showed that Left (OR 2.01, 95% CI 1.04–3.86), and Right (OR 1.5, 95% CI 1.04–2.25) moderate and severe ventricular enlargement, Vasoactive-Inotropic Score (VIS) one hour before CKRT initiation (OR 1.18 per 10 units increase, 95% CI 1.09–1.28) and high bicarbonate fluid replacement (OR 2.52, 95% CI 1.01–6.2) were associated with hypotension after CKRT initiation. Conclusion Right and left ventricular enlargement are risk factors associated with hypotension after CKRT initiation.
Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Prostatectomy on Trifecta Outcomes: A Randomized Clinical Trial
Shirk, Joseph D. , Reiter, Robert E. , Wallen, Eric, Pak, Ray , Badani, Ketan K. , Porter, James , Ahlering, Thomas E.

Mayo Clinic

Journal of Urology | July 18, 2022 | Volume: 208 | Issue: 3 | Pages: 618-625

10.1097/ju.0000000000002719 | PMID 35848770 Get It

Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy
Gallicano, G. Ian , Fu, Jiayu , Mahapatra, Samiksha , Sharma, Michael V. R., Dillon, Conor, Deng, Claire, Zahid, Maliha

Mayo Clinic

Pharmaceuticals | July 18, 2022 | Volume: 15 | Issue: 7 | Pages: 871

10.3390/ph15070871 | PMID 35890169 Get It

Causes and treatments for heart failure (HF) have been investigated for over a century culminating in data that have led to numerous pharmacological and surgical therapies. Unfortunately, to date, even with the most current treatments, HF remains a progressive disease with no therapies targeting the cardiomyocytes directly. Technological advances within the past two to three years have brought about new paradigms for treating many diseases that previously had been extremely difficult to resolve. One of these new paradigms has been a shift from pharmacological agents to antisense technology (e.g., microRNAs) to target the molecular underpinnings of pathological processes leading to disease onset. Although this paradigm shift may have been postulated over a decade ago, only within the past few years has it become feasible. Here, we show that miRNA106a targets genes that, when misregulated, have been shown to cause hypertrophy and eventual HF. The addition of miRNA106a suppresses misexpressed HF genes and reverses hypertrophy. Most importantly, using a cardiac targeting peptide reversibly linked to miRNA106a, we show delivery is specific to cardiomyocytes.
Human Granulocytic Anaplasmosis—A Systematic Review of Published Cases
Dumic, Igor , Jevtic, Dorde , Veselinovic, Mladjen, Nordstrom, Charles W. , Mogulla, Vanajakshi , Veselinovic, Elmira Mofid, Hudson, Ann, Simeunovic, Gordana , Petcu, Emilia, Ramanan, Poornima , Dumic, Igor , Jevtic, Djordje , Jovanovic, Milan D.

Mayo Clinic

Microorganisms | July 18, 2022 | Volume: 10 | Issue: 7 | Pages: 1433

10.3390/microorganisms10071433 | PMID 35889152 Get It

Anaplasma phagocytophilum is an emerging, Gram-negative, obligate intracellular pathogen that is transmitted by a tick vector. Human infection ranges from asymptomatic to severe disease that can present with pancytopenia, multiorgan failure, and death. The aim of this systematic review is to analyze case reports and case series reported over the last two decades in peer-reviewed journals indexed in the Medline/PubMed database according to the PRISMA guidelines. We found 110 unique patients from 88 case reports and series. The most common mode of transmission was tick bite (60.9%), followed by blood transfusion (8.2%). Infection was acquired by blood transfusion in nearly half (42%) of the immunocompromised patients. Most patients reported fever (90%), followed by constitutional (59%) and gastrointestinal symptoms (56%). Rash was present in 17% of patients, much higher than in previous studies. Thrombocytopenia was the most common laboratory abnormality (76%) followed by elevated aspartate aminotransferase (AST) (46%). The diagnosis was most commonly established using whole-blood polymerase chain reaction (PCR) in 76% of patients. Coinfection rate was 9.1% and Borrelia burgdorferi was most commonly isolated in seven patients (6.4%). Doxycycline was used to treat 70% of patients but was only used as an empiric treatment in one-third of patients (33.6%). The overall mortality rate was 5.7%, and one patient died from trauma unrelated to HGA. The mortality rates among immunocompetent and immunocompromised patients were 4.2% (n = 4/95) and 18.2% (n = 2/11), respectively. Four of the six patients who died (66.6%) received appropriate antibiotic therapy. Among these, doxycycline was delayed by more than 48 h in two patients.
Greater Muscular Strength Is Associated with a Lower Risk of Pulmonary Dysfunction in Individuals with Non-Alcoholic Fatty Liver Disease
Johnson, Bruce D., Watt, Kymberly D. , Kim, Chul-Ho, Kim, Chul‐Ho , Cho, Jinkyung , Watt, K D , Kim, Chul-Ho , Kim, Chul-Ho

Mayo Clinic

Journal of Clinical Medicine | July 17, 2022 | Volume: 11 | Issue: 14 | Pages: 4151

10.3390/jcm11144151 | PMID 35887915 Get It

This study investigated the combined effect of handgrip strength (HGS) and non-alcoholic fatty liver disease (NAFLD) on pulmonary function using the Korea National Health and Nutrition Examination Survey (KNHANES) from 2016 to 2018. For the present study, forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), the FEV1/FVC ratio, handgrip strength (HGS) and the hepatic steatosis index (HSI) to estimate NAFLD were obtained from nationwide cross-sectional surveys. For HGS, subjects were divided into higher HGS (upper 50%) and lower HGS (lower 50%). For NAFLD, subjects were divided into the NAFLD cohort (HSI > 36) and the normal cohort (HSI ≤ 36). Of 1651 subjects (men, n = 601), 25.5% of subjects (n = 421) met the HSI > 36. Based on the normal cohort with high HGS, the normal cohort with low HGS showed an increased risk of reduced FVC (OR = 3.062, 95% CI = 2.46–4.83, p < 0.001) and the NAFLD cohort with low HGS showed a further increased risk of reduced FVC (OR = 4.489, 95% CI = 3.43–7.09, p < 0.001). However, the risk of reduced FVC was not significantly increased in NAFLD with high HGS (OR = 1.297, 95% CI = 0.67–2.50, p = 0.436). After adjusted for covariates such as age, sex, smoking, FBG, HDL-C, TG, SBP, DBP, CRP and alcohol consumption, the results remained similar. More importantly, these results were consistent in the obesity-stratified analysis. The current findings of the study suggest that higher muscle strength is associated with a lower risk of reduced pulmonary function in individuals with NAFLD.
Influenza Myopericarditis and Pericarditis: A Literature Review
Radovanovic, Milan , Petrović, Marija , Barsoum, Michel K., Nordstrom, Charles W. , Calvin, Andrew D. , Dumic, Igor , Jevtic, Dorde , Hanna, Richard D. , Dumic, Igor , Jevtic, Djordje , Calvin, Andrew D

Mayo Clinic

Journal of Clinical Medicine | July 17, 2022 | Volume: 11 | Issue: 14 | Pages: 4123

10.3390/jcm11144123 | PMID 35887887 Get It

Myopericarditis is a rare complication of influenza infection. The presentation may range from mild and frequently unrecognized, to fulminant and potentially complicated by cardiogenic and/or obstructive shock (tamponade), which is associated with high mortality. We performed a review of literature on all influenza pericarditis and myopericarditis cases according to PRISMA guidelines using the PubMed search engine of the Medline database. Seventy-five cases of influenza myopericarditis and isolated pericarditis were identified from 1951 to 2021. Influenza A was reported twice as often as influenza B; however, influenza type did not correlate with outcome. Men and elderly patients were more likely to have isolated pericarditis, while women and younger patients were more likely to have myopericarditis. All included patients had pericardial effusion, while 36% had tamponade. Tamponade was more common in those with isolated pericarditis (41.2%) than myopericarditis (13.8%). Cardiogenic shock was more common in patients with myopericarditis (64%), with an overall mortality rate of 14.7%. Nearly 88% of the recovered patients remained without long-term complications reported. Conclusion: Influenza A appears a more common cause of pericarditis and myopericarditis. Isolated pericarditis was more commonly associated with tamponade but without reported deaths, whereas myopericarditis was more commonly associated with cardiogenic shock and death (19%).
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter’s Trans-Formed DLBCL and Germinal Center B-Cells
Uhl, Barbara , Pansy, Katrin , Wenzl, Kerstin , Strobl, Johanna , Baumgartner, Claudia , Szmyra, Marta , Waha, James Elvis, Wolf, Axel , Tomazic, Peter Valentin , Steinbauer, Elisabeth, Steinwender, Maria, Friedl, Sabine, Weniger, Marc A., Küppers, Ralf , Pichler, Martin , Greinix, Hildegard , Ramsay, Alan G. , Apollonio, Benedetta , Feichtinger, Julia , Beham‐Schmid, Christine, Neumeister, Peter , Deutsch, Alexander , Pansy, Katrin , Strobl, Johanna , Küppers, Ralf , Pichler, Martin , Ramsay, Alan G , Feichtinger, Julia , Deutsch, Alexander J , Prochazka, Katharina Theresa , Baumgartner, Claudia, Stary, Georg

Mayo Clinic

International Journal of Molecular Sciences | July 17, 2022 | Volume: 23 | Issue: 14 | Pages: 7874

10.3390/ijms23147874 | PMID 35887224 Get It

Chemokine receptors and their ligands have been identified as playing an important role in the development of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and Richter syndrome (RS). Our aim was to investigate the different expression profiles in de novo DLBCL, transformed follicular lymphoma (tFL), and RS. Here, we profiled the mRNA expression levels of 18 chemokine receptors (CCR1–CCR9, CXCR1–CXCR7, CX3CR1 and XCR1) using RQ-PCR, as well as immunohistochemistry of seven chemokine receptors (CCR1, CCR4–CCR8 and CXCR2) in RS, de novo DLBCL, and tFL biopsy-derived tissues. Tonsil-derived germinal center B-cells (GC-B) served as non-neoplastic controls. The chemokine receptor expression profiles of de novo DLBCL and tFL substantially differed from those of GC-B, with at least 5-fold higher expression of 15 out of the 18 investigated chemokine receptors (CCR1–CCR9, CXCR1, CXCR2, CXCR6, CXCR7, CX3CR1 and XCR1) in these lymphoma subtypes. Interestingly, the de novo DLBCL and tFL exhibited at least 22-fold higher expression of CCR1, CCR5, CCR8, and CXCR6 compared with RS, whereas no significant difference in chemokine receptor expression profile was detected when comparing de novo DLBCL with tFL. Furthermore, in de novo DLBCL and tFLs, a high expression of CCR7 was associated with a poor overall survival in our study cohort, as well as in an independent patient cohort. Our data indicate that the chemokine receptor expression profile of RS differs substantially from that of de novo DLBCL and tFL. Thus, these multiple dysregulated chemokine receptors could represent novel clinical markers as diagnostic and prognostic tools. Moreover, this study highlights the relevance of chemokine signaling crosstalk in the tumor microenvironment of aggressive lymphomas.
Medical Malpractice Lawsuits Involving Trainees in Obstetrics and Gynecology in the USA
Ghaith, Summer , Torbenson, Vanessa E. , Lindor, Rachel A. , Lindor, Rachel A , Campbell, Ronna L. , Pollock, Jordan Riley

Mayo Clinic

Healthcare | July 17, 2022 | Volume: 10 | Issue: 7 | Pages: 1328

10.3390/healthcare10071328 | PMID 35885853 Get It

Background: While the liability risks for obstetrics and gynecology (ob/gyn) physicians are widely recognized, little is known about how trainees have been involved in ob/gyn lawsuits. Objectives: To characterize involvement of trainees in malpractice lawsuits related to ob/gyn. Methods: The legal database Westlaw was utilized to collect ob/gyn-related malpractice lawsuits involving trainees reported from 1986 to 2020 in the USA. Outcome: Forty-six malpractice cases involving ob/gyn trainees were identified, including 34 cases related to obstetrics and 12 to gynecology. There were 11 cases alleging lack of informed consent, including 7 cases alleging lack of consent for trainee involvement. Of the 34 obstetrics cases, 27 related to procedural complications, 17 to treatment, 13 to diagnosis, and 4 to informed consent. Of these, 17 were decided in favor of the physician, 6 resulted in findings of negligence, 9 had unknown outcomes, and 3 ended in settlement. For the 6 cases ending in a finding of negligence, the mean award was $2,174,472 compared to $685,000 for those that were settled. Of the 12 gynecology cases, 8 related to procedural complications, 7 to informed consent, 3 to diagnosis, and 2 to treatment. Of these, 6 were decided in favor of the physician, 3 resulted in findings of negligence, and 3 had unknown outcomes. For the cases ending in a finding of negligence, the mean award was $465,000. Conclusions and Outlook: This review of malpractice cases highlights types of situations in which trainees are sued and reveals the importance of designing curriculum around faculty training and supervision regarding trainee involvement in patient care.
Including diverse and admixed populations in genetic epidemiology research
Caliebe, Amke , Tekola‐Ayele, Fasil , Darst, Burcu F. , Wang, Xuexia , Song, Yeunjoo E. , Sebro, Ronnie , Balding, David J. , Saad, Mohamad , Dubé, Marie‐Pierre , Sebro, Ronnie A, Dubé, Marie-Pierre , Darst, Burcu F , Gui, Jiang

Mayo Clinic

Genetic Epidemiology | July 17, 2022 | Volume: 46 | Issue: 7 | Pages: 347-371

10.1002/gepi.22492 | PMID 35842778 Get It

AbstractThe inclusion of ancestrally diverse participants in genetic studies can lead to new discoveries and is important to ensure equitable health care benefit from research advances. Here, members of the Ethical, Legal, Social, Implications (ELSI) committee of the International Genetic Epidemiology Society (IGES) offer perspectives on methods and analysis tools for the conduct of inclusive genetic epidemiology research, with a focus on admixed and ancestrally diverse populations in support of reproducible research practices. We emphasize the importance of distinguishing socially defined population categorizations from genetic ancestry in the design, analysis, reporting, and interpretation of genetic epidemiology research findings. Finally, we discuss the current state of genomic resources used in genetic association studies, functional interpretation, and clinical and public health translation of genomic findings with respect to diverse populations.
Urticaria and/or angioedema secondary to mRNA COVID ‐19 vaccines: Updates from a United States case registry
Anvari, Sara , Jaggers, Jordan, Gonzalez‐Estrada, Alexei , Chong, Hey , Meerbeke, Sara W. Van, Petrov, Andrej A. , Khan, David A. , Freeman, Esther E. , Banerji, Aleena , Blumenthal, Kimberly G. , Gonzalez-Estrada, Alexei , Blumenthal, Kimberly G , Samarakoon, Upeka , Fu, Xiaoqing

Mayo Clinic

Allergy | July 17, 2022 | Volume: 78 | Issue: 1 | Pages: 283-286

10.1111/all.15447 | PMID 35842747 Get It